Pfizer Pre-Tax Income 2010-2024 | PFE

Pfizer pre-tax income for the twelve months ending September 30, 2024 was $3.904B, a 62.53% decline year-over-year.

  • Pfizer annual pre-tax income for 2023 was $1.058B, a 96.95% decline from 2022.
  • Pfizer annual pre-tax income for 2022 was $34.729B, a 42.85% increase from 2021.
  • Pfizer annual pre-tax income for 2021 was $24.311B, a 245.52% increase from 2020.

Pfizer Pre-Tax Income 2010-2024 | PFE

  • Pfizer annual pre-tax income for 2023 was $1.058B, a 96.95% decline from 2022.
  • Pfizer annual pre-tax income for 2022 was $34.729B, a 42.85% increase from 2021.
  • Pfizer annual pre-tax income for 2021 was $24.311B, a 245.52% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B